Production and characterization of a chimeric antigen, based on nucleocapsid of SARS-CoV-2 fused to the extracellular domain of human CD154 in HEK-293 cells as a vaccine candidate against COVID-19
| Main Authors: | , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2023-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10522030/?tool=EBI |
| _version_ | 1797671325398990848 |
|---|---|
| author | Thailin Lao Ileanet Avalos Elsa María Rodríguez Yasser Zamora Alianet Rodriguez Ailyn Ramón Yanitza Alvarez Ania Cabrales Ivan Andújar Luis Javier González Pedro Puente Cristina García Leonardo Gómez Rodolfo Valdés Mario Pablo Estrada Yamila Carpio |
| author_facet | Thailin Lao Ileanet Avalos Elsa María Rodríguez Yasser Zamora Alianet Rodriguez Ailyn Ramón Yanitza Alvarez Ania Cabrales Ivan Andújar Luis Javier González Pedro Puente Cristina García Leonardo Gómez Rodolfo Valdés Mario Pablo Estrada Yamila Carpio |
| author_sort | Thailin Lao |
| collection | DOAJ |
| first_indexed | 2024-03-11T21:13:42Z |
| format | Article |
| id | doaj.art-495fcb5893934a5583f0d178b40ddce6 |
| institution | Directory Open Access Journal |
| issn | 1932-6203 |
| language | English |
| last_indexed | 2024-03-11T21:13:42Z |
| publishDate | 2023-01-01 |
| publisher | Public Library of Science (PLoS) |
| record_format | Article |
| series | PLoS ONE |
| spelling | doaj.art-495fcb5893934a5583f0d178b40ddce62023-09-29T05:31:34ZengPublic Library of Science (PLoS)PLoS ONE1932-62032023-01-01189Production and characterization of a chimeric antigen, based on nucleocapsid of SARS-CoV-2 fused to the extracellular domain of human CD154 in HEK-293 cells as a vaccine candidate against COVID-19Thailin LaoIleanet AvalosElsa María RodríguezYasser ZamoraAlianet RodriguezAilyn RamónYanitza AlvarezAnia CabralesIvan AndújarLuis Javier GonzálezPedro PuenteCristina GarcíaLeonardo GómezRodolfo ValdésMario Pablo EstradaYamila Carpiohttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC10522030/?tool=EBI |
| spellingShingle | Thailin Lao Ileanet Avalos Elsa María Rodríguez Yasser Zamora Alianet Rodriguez Ailyn Ramón Yanitza Alvarez Ania Cabrales Ivan Andújar Luis Javier González Pedro Puente Cristina García Leonardo Gómez Rodolfo Valdés Mario Pablo Estrada Yamila Carpio Production and characterization of a chimeric antigen, based on nucleocapsid of SARS-CoV-2 fused to the extracellular domain of human CD154 in HEK-293 cells as a vaccine candidate against COVID-19 PLoS ONE |
| title | Production and characterization of a chimeric antigen, based on nucleocapsid of SARS-CoV-2 fused to the extracellular domain of human CD154 in HEK-293 cells as a vaccine candidate against COVID-19 |
| title_full | Production and characterization of a chimeric antigen, based on nucleocapsid of SARS-CoV-2 fused to the extracellular domain of human CD154 in HEK-293 cells as a vaccine candidate against COVID-19 |
| title_fullStr | Production and characterization of a chimeric antigen, based on nucleocapsid of SARS-CoV-2 fused to the extracellular domain of human CD154 in HEK-293 cells as a vaccine candidate against COVID-19 |
| title_full_unstemmed | Production and characterization of a chimeric antigen, based on nucleocapsid of SARS-CoV-2 fused to the extracellular domain of human CD154 in HEK-293 cells as a vaccine candidate against COVID-19 |
| title_short | Production and characterization of a chimeric antigen, based on nucleocapsid of SARS-CoV-2 fused to the extracellular domain of human CD154 in HEK-293 cells as a vaccine candidate against COVID-19 |
| title_sort | production and characterization of a chimeric antigen based on nucleocapsid of sars cov 2 fused to the extracellular domain of human cd154 in hek 293 cells as a vaccine candidate against covid 19 |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10522030/?tool=EBI |
| work_keys_str_mv | AT thailinlao productionandcharacterizationofachimericantigenbasedonnucleocapsidofsarscov2fusedtotheextracellulardomainofhumancd154inhek293cellsasavaccinecandidateagainstcovid19 AT ileanetavalos productionandcharacterizationofachimericantigenbasedonnucleocapsidofsarscov2fusedtotheextracellulardomainofhumancd154inhek293cellsasavaccinecandidateagainstcovid19 AT elsamariarodriguez productionandcharacterizationofachimericantigenbasedonnucleocapsidofsarscov2fusedtotheextracellulardomainofhumancd154inhek293cellsasavaccinecandidateagainstcovid19 AT yasserzamora productionandcharacterizationofachimericantigenbasedonnucleocapsidofsarscov2fusedtotheextracellulardomainofhumancd154inhek293cellsasavaccinecandidateagainstcovid19 AT alianetrodriguez productionandcharacterizationofachimericantigenbasedonnucleocapsidofsarscov2fusedtotheextracellulardomainofhumancd154inhek293cellsasavaccinecandidateagainstcovid19 AT ailynramon productionandcharacterizationofachimericantigenbasedonnucleocapsidofsarscov2fusedtotheextracellulardomainofhumancd154inhek293cellsasavaccinecandidateagainstcovid19 AT yanitzaalvarez productionandcharacterizationofachimericantigenbasedonnucleocapsidofsarscov2fusedtotheextracellulardomainofhumancd154inhek293cellsasavaccinecandidateagainstcovid19 AT aniacabrales productionandcharacterizationofachimericantigenbasedonnucleocapsidofsarscov2fusedtotheextracellulardomainofhumancd154inhek293cellsasavaccinecandidateagainstcovid19 AT ivanandujar productionandcharacterizationofachimericantigenbasedonnucleocapsidofsarscov2fusedtotheextracellulardomainofhumancd154inhek293cellsasavaccinecandidateagainstcovid19 AT luisjaviergonzalez productionandcharacterizationofachimericantigenbasedonnucleocapsidofsarscov2fusedtotheextracellulardomainofhumancd154inhek293cellsasavaccinecandidateagainstcovid19 AT pedropuente productionandcharacterizationofachimericantigenbasedonnucleocapsidofsarscov2fusedtotheextracellulardomainofhumancd154inhek293cellsasavaccinecandidateagainstcovid19 AT cristinagarcia productionandcharacterizationofachimericantigenbasedonnucleocapsidofsarscov2fusedtotheextracellulardomainofhumancd154inhek293cellsasavaccinecandidateagainstcovid19 AT leonardogomez productionandcharacterizationofachimericantigenbasedonnucleocapsidofsarscov2fusedtotheextracellulardomainofhumancd154inhek293cellsasavaccinecandidateagainstcovid19 AT rodolfovaldes productionandcharacterizationofachimericantigenbasedonnucleocapsidofsarscov2fusedtotheextracellulardomainofhumancd154inhek293cellsasavaccinecandidateagainstcovid19 AT mariopabloestrada productionandcharacterizationofachimericantigenbasedonnucleocapsidofsarscov2fusedtotheextracellulardomainofhumancd154inhek293cellsasavaccinecandidateagainstcovid19 AT yamilacarpio productionandcharacterizationofachimericantigenbasedonnucleocapsidofsarscov2fusedtotheextracellulardomainofhumancd154inhek293cellsasavaccinecandidateagainstcovid19 |